UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma

Hepatology international, 2024-06, Vol.18 (3), p.973-983

2024

Volltextzugriff (PDF)

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Cancer, 2008-06, Vol.112 (11), p.2368-2376

2008

Volltextzugriff (PDF)

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Journal of cancer education, 2020-06, Vol.35 (3), p.545-556

2020

Volltextzugriff (PDF)

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

The lancet oncology, 2014-11, Vol.15 (12), p.1389-1396

2014

Volltextzugriff (PDF)

Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-11, Vol.20 (6), p.970-977

2017

Volltextzugriff (PDF)

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-04, Vol.19 (2), p.586-596

2016

Volltextzugriff (PDF)

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Vol.20 (1), p.146-155

2017

Volltextzugriff (PDF)

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-09, Vol.21 (5), p.802-810

2018

Volltextzugriff (PDF)

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Vol.20 (1), p.182-189

2017

Volltextzugriff (PDF)

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

Cancer chemotherapy and pharmacology, 2011, Vol.67 (1), p.127-136

2011

Volltextzugriff (PDF)

Gastric cancer patients at high-risk of having synchronous cancer

World journal of gastroenterology : WJG, 2006-04, Vol.12 (16), p.2588

2006

Volltextzugriff (PDF)

Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer

Surgical endoscopy, 2011-05, Vol.25 (5), p.1505-1513

2011

Volltextzugriff (PDF)

Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer

Journal of gastroenterology, 2006-04, Vol.41 (4), p.339-346

2006

Volltextzugriff (PDF)

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients

Cancer chemotherapy and pharmacology, 2010-02, Vol.65 (3), p.579-587

2010

Volltextzugriff (PDF)

Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer

Hepato-gastroenterology, 2012-03, Vol.59 (114), p.430

2012

Volltextzugriff (PDF)

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

Annals of surgical oncology, 2010-12, Vol.17 (12), p.3163-3172

2010

Volltextzugriff (PDF)

Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: Results of prospective single center trials

Journal of surgical oncology, 2009-03, Vol.99 (3), p.137-142

2009

Volltextzugriff (PDF)

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer

Pharmacogenomics, 2009-07, Vol.10 (7), p.1147-1155

2009

Volltextzugriff (PDF)

Effective diameter of balloon dilation for benign esophagojejunal anastomotic stricture after total gastrectomy

Surgical endoscopy, 2009-08, Vol.23 (8), p.1775-1780

2009

Volltextzugriff (PDF)

Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study

Cancer chemotherapy and pharmacology, 2008-07, Vol.62 (2), p.263-270

2008

Volltextzugriff (PDF)

Comparison of Intrathecal Chemotherapy for Leptomeningeal Carcinomatosis of a Solid Tumor: Methotrexate Alone Versus Methotrexate in Combination with Cytosine Arabinoside and Hydrocortisone

Japanese journal of clinical oncology, 2003-12, Vol.33 (12), p.608-612

2003

Volltextzugriff (PDF)

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach

British journal of cancer, 2017-06, Vol.117 (1), p.25-32

2017

Volltextzugriff (PDF)

Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (10), p.7547-7555

2023

Volltextzugriff (PDF)

Decisions for extent of gastric surgery in gastric cancer patients: Younger patients require more attention than the elderly

Journal of surgical oncology, 2007-05, Vol.95 (6), p.485-490

2007

Volltextzugriff (PDF)

A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer

European journal of cancer (1990), 2017-09, Vol.83, p.32-42

2017

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(56)
Male
(56)
Middle Aged
(56)
Female
(55)
Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Adult
(47)
Oncology
(33)
Stomach Neoplasms - Pathology
(28)
Gastric Cancer
(25)
Stomach Neoplasms - Drug Therapy
(23)
Medicine
(19)
Treatment Outcome
(19)
Aged, 80 And Over
(18)
Medicine & Public Health
(18)
Retrospective Studies
(17)
Stomach Neoplasms - Surgery
(17)
Surgery
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

Gastric cancer patients at high-risk of having synchronous cancer

Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer

Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients

Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: Results of prospective single center trials

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer

Effective diameter of balloon dilation for benign esophagojejunal anastomotic stricture after total gastrectomy

Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study

Comparison of Intrathecal Chemotherapy for Leptomeningeal Carcinomatosis of a Solid Tumor: Methotrexate Alone Versus Methotrexate in Combination with Cytosine Arabinoside and Hydrocortisone

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach

Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma

Decisions for extent of gastric surgery in gastric cancer patients: Younger patients require more attention than the elderly

A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer

Aktive Filter

Suchergebnisse filtern